New combo aims to shield heart while fighting tumors

NCT ID NCT06815575

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests a new drug called RC220 given with the chemotherapy doxorubicin in adults with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to find a safe dose and see if RC220 can protect the heart from doxorubicin's side effects. About 53 participants will take part across multiple centers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asan Medical Centre

    NOT_YET_RECRUITING

    Seoul, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Cancer Care Foundation

    RECRUITING

    Miranda, New South Wales, 2228, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ewha Womans University MokDong Hospital

    NOT_YET_RECRUITING

    Seoul, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Gosford Hospital

    RECRUITING

    Gosford, New South Wales, 2250, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Prince of Wales Hospital

    RECRUITING

    Shatin, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Queen Mary Hospital

    RECRUITING

    Hong Kong, 999077, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Samsung Medical Centre

    NOT_YET_RECRUITING

    Seoul, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Severance Hospital, Yonsei University, Health System

    NOT_YET_RECRUITING

    Seoul, South Korea

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Wyong Hospital

    RECRUITING

    Wyong, New South Wales, 2259, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••